245 related articles for article (PubMed ID: 33783763)
1. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Haranishi Y; Hara K; Terada T
Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
[TBL] [Abstract][Full Text] [Related]
2. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
3. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid activation of CB
Sun L; Tai L; Qiu Q; Mitchell R; Fleetwood-Walker S; Joosten EA; Cheung CW
Eur J Pain; 2017 May; 21(5):804-814. PubMed ID: 28107590
[TBL] [Abstract][Full Text] [Related]
6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
7. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
8. Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain.
Haranishi Y; Hara K; Terada T
Pharmacol Biochem Behav; 2020 Aug; 195():172964. PubMed ID: 32504731
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
Palazzo E; de Novellis V; Petrosino S; Marabese I; Vita D; Giordano C; Di Marzo V; Mangoni GS; Rossi F; Maione S
Eur J Neurosci; 2006 Oct; 24(7):2011-20. PubMed ID: 17040473
[TBL] [Abstract][Full Text] [Related]
10. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
11. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
12. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
13. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
Thomas A; Okine BN; Finn DP; Masocha W
Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
[TBL] [Abstract][Full Text] [Related]
14. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
15. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Schreiber AK; Neufeld M; Jesus CH; Cunha JM
Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
[TBL] [Abstract][Full Text] [Related]
16. CB
Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
[TBL] [Abstract][Full Text] [Related]
17. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
18. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
[TBL] [Abstract][Full Text] [Related]
19. Verbascoside administered intrathecally attenuates hyperalgesia via activating mu-opioid receptors in a rat chronic constriction injury model.
Hara K; Haranishi Y; Terada T
Eur J Pain; 2022 Jul; 26(6):1322-1332. PubMed ID: 35437876
[TBL] [Abstract][Full Text] [Related]
20. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
